Pharmaceutical Patient Assistance Programs
Adaptive Biotechnologies understands that each patient's situation is unique. We are committed to providing guidance and support during each step of the insurance process.
That's why we offer the Adaptive Assist program: to help facilitate access to clonoSEQ testing services for patients who could benefit from the clinical insights provided by next-generation measurable residual (MRD) testing.
If you are being treated with ZYNLONTA®, ADVANCING Patient Support offers help throughout your treatment. Whether you need assistance with your health insurance or help planning a conversation with your healthcare provider, you can rely on your dedicated case manager and our many program services to provide you with personalized support—so you can focus more on what’s important to you.
- If you are commercially insured and eligible, helps your healthcare provider enroll you in the copay program, in which you could pay as little as $0 per dosea
- If you are uninsured or underinsured, assesses if you are eligible for the patient assistance program to cover your costs of therapy
Phone 1-855-690-0340 | Fax 1-855-915-3005 | Email support@ADVANCINGPatientSupport.com
Alnylam Assist® offers support services to help your patients access Alnylam products. Alnylam Field Reimbursement Directors are available to answer coverage, coding, and reimbursement-related questions about Alnylam products.
Alnylam offers financial assistance programs for eligible patients. After being prescribed an Alnylam product, your patient can talk to an Alnylam Case Manager to learn more. Below are examples of two Alnylam financial assistance programs.*
- Patient Assistance Program (PAP): Provides Alnylam product at no cost to eligible patients, primarily the uninsured, who meet specified financial criteria
- Commercial Copay Program: Covers certain out-of-pocket costs for eligible patients with commercial insurance. †
Learn more at: https://www.alnylamassist.com/givlaari/hcp
*Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue any program at any time.
†Patients with Medicare, Medicaid, or other government-sponsored insurance are not eligible for the Alnylam Assist® Commercial Copay Program. Out-of-pocket costs for the administration of Alnylam products will not be covered for patients residing where it is prohibited by law or where otherwise restricted.
To view the provider brochure, please click here.
The Neulasta FIRST STEP™ Program is intended to provide assistance to eligible low-income patients who need help meeting their Neulasta® co-insurance or co-payment requirement.
The Safety Net Foundation is a non-profit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost.
Main Fax: 877-727-2867
Helping patients save on KRAS G12C testing
1 in 8 people living with non-small cell lung cancer (NSCLC*) have the KRAS G12C gene mutation.1 Testing for biomarkers like KRAS G12C is important because it can help your doctor tailor your treatment plan.2
Biomarker Assist can help you save on the cost for KRAS G12C testing. Program limitations apply, please see terms and conditions including limits on individual program coverages.
Astellas Pharma Support Solutions offers access and reimbursement support to help patients overcome challenges to accessing Astellas products. Watch the “We Are With You” video here.
Helping Patients Access the Care They Need
The AstraZeneca Access 360TM program provides personal support to help streamline access and reimbursement for select AstraZeneca medicines. Access 360 provides:
- Assistance with understanding patient insurance coverage and pharmacy options
- Prior authorization support
- Claims and appeal process support
To learn more about the Access 360 program, please call 1-844-ASK-A360 (1-844-275-2360) Monday – Friday, 8 AM - 8 PM EST or visit www.MyAccess360.com.
If you take certain AstraZeneca medicines, and you cannot afford them, you may be surprised to learn that AstraZeneca may be able to help. Our programs are designed to help qualifying people without insurance, those in Medicare Part D, and those who have faced a financial crisis recently.
If you want to determine which AZ&Me Prescription Savings Program you may be eligible for, please read more about each program or call us at 1-800-AZandMe (292-6363).
AVEO ACE is a comprehensive program dedicated to providing personalized support to patients and their loved ones throughout the FOTIVDA treatment journey.
Once you and your healthcare professional have decided that FOTIVDA is right for you, an AVEO ACE Program Specialist is available to:
- Explain your insurance coverage for FOTIVDA
- Connect you to resources to help you access your FOTIVDA treatment
- Provide ongoing education and support to assist during your treatment journey
1-833-FOTIVDA (Monday through Friday, 8 AM-8 PM ET)
The BI Cares Patient Assistance Program is a charitable program provided by the Boehringer Ingelheim Cares Foundation (BI Cares), an independent nonprofit organization, to improve patients’ health and lives.
BMS Access Support® is focused on helping patients access our medications. Get enrollment forms, billing codes, and other access and reimbursement information.
At Coherus BioSciences, we’re committed to ensuring that patients have access to biologics such as Udenyca and Cimerli. Coherus Solutions provides patient support services and programs designed to assist with patient access.
A SINGLE SOURCE FOR SUPPORT
While other people may be on the same medication as you, your treatment journey is personal and uniquely your own. And that's why Daiichi Sankyo Access Central was created: to bring your needs into focus. Our goal is to help you gain access to the medication, support, and information you need to start and continue your treatment journey. Select a Daiichi Sankyo product to learn more about how our programs and resources can help you.
Insurance questions? Cost concerns? LET US POINT THE WAY. Count on our dedicated Case Managers for help with your insurance issues.
Our Case Managers are readily available to answer your insurance questions.
- Call us at 1-833-4DACCES (1-833-432-2237) Monday–Friday 8AM–8PM ET
- Or email firstname.lastname@example.org to schedule a call back
Providing you and your patients comprehensive reimbursement and access solutions. EAGLE CAN® offers reliable support for eligible patients prescribed PEMFEXY® (pemetrexed injection) or BELRAPZO® (bendamustine HCl injection).
- Benefit verification
- Prior authorization assistance
- Product access through our Patient Financial Assistance Program (for eligibility requirements please contact a program representative)
- PEMFEXY Copay Assistance Program
Monday through Friday, 9 AM to 5 PM ET
At Eisai, everything we do is guided by a simple principle: patients and their families come first and we have a responsibility to listen to and learn from them. We call this human health care, or hhc.
For program and eligibility information, and to review the program terms and conditions,
please visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724)
Support may include:
- Access – ENHERTU4U can help with benefit verifications and understanding prior authorizations.
- Affordability – Multiple options are available to help eligible patients afford their treatment.
- Coding and Reimbursement – Coding, appeals, and denial information is available to help with reimbursement.
- Distribution – ENHERTU is available through a network of select specialty distributors and specialty pharmacies.
If you have questions, call 1-833-ENHERTU (1-833-364-3788) or visit www.ENHERTU4U.com.
Customer support page: www.oncotypedx.com.
Roxanne Boczar: 734-260-3216
Exelixis Access Services® (EASE) provides a variety of support to help your patients start treatment quickly. EASE can help meet the unique needs of your patients and practice at each step along the access journey.
Help Patients Start and Stay Provides proactive follow-up on CABOMETYX® (cabozantinib)
- 30-Day Free Trial Program At your request, EASE can provide support with:
- Provides a free trial to help new CABOMETYX patients start treatment quickly, regardless of insurance type, with a 30-day additional supply available for patients with a payer decision delay of 5 days or more
- Co-Pay Program
- Eligible, commercially insured patients may pay as little as $0 per month. Annual and transaction limits apply
- Dose Exchange Program
- Provides a free 15-tablet supply in the lower dose to help patients who require a dose reduction
- Patient Assistance Program
- Eligible patients who cannot afford their drug costs may receive CABOMETYX free of charge
EASE offers regionally dedicated Case Managers as a single point of contact.
- Offers prompt support with payer coverage, financial assistance, and treatment coordination
- Can provide the status of your patients' access journey
- Help Patients Start and Stay Provides proactive follow-up
CONTACT EASE FOR MORE INFORMATION AND TO ENROLL
CALL: 1-844-900-EASE (1-844-900-3273) Monday to Friday, 8:00 AM to 8:00 PM (ET)
FAX: 1-844-901-EASE (1-844-901-3273)
Health insurance coverage and reimbursement issues can be confusing and challenging. Genentech Access Solutions is here to make the process as easy as possible.
IMBRUVICA® By Your Side* is a patient program designed specifically to support IMBRUVICA® prescribed patients.
*IMBRUVICA® By Your Side patient support program is not intended to provide medical advice, replace prescribed treatment plans, or provide treatment or case management services. Patients are advised to talk to their healthcare provider and treatment team about any medical decisions or concerns they may have.
IncyteCARES: We’re Here to Help Patients During Treatment.
We offer support for eligible patients during treatment, including a program that could make your copay as little as $0.*
To view the brochure, click here.
IPSEN CARES serves as a central point of contact between patients/caregivers, healthcare providers, insurance companies, and Specialty Pharmacies.
To learn more, visit www.ipsencares.com or call us at 1-866-435-5677 8AM-8PM ET, Monday – Friday
Support for patients and their caregivers.
Once you and your doctor have decided that a Janssen medication is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. We will give you information on insurance coverage and treatment support, and identify options that may help make your treatment more affordable.
Call a Janssen CarePath Care Coordinator today at 877-CarePath (877-227-3728), Monday–Friday, 8:00 AM to 8:00 PM ET, create a Janssen CarePath Account at MyJanssenCarePath.com or visit JanssenCarePath.com
Jazz Pharmaceuticals recognizes that many patients today face financial obstacles that keep them from accessing important medications. We are committed to improving patient care through unique patient and physician programs and ongoing collaboration with patients, physicians and advocacy groups.
JazzCares support may include:
- Help understanding your insurance coverage: benefit verification, prior authorization, and/or appeals support
- Help paying for your medication: out-of-pocket cost assistance for eligible patients
- Free drug: product at no cost for eligible patients
JazzCares is here to help you Monday through Friday 8am ET to 8pm ET. You can seamlessly enroll into JazzCares online or learn more about JazzCares at www.JazzCares.com or by calling 1-833-533-JAZZ (5299).
Karyopharm Therapeutics® Inc. is dedicated to providing assistance and resources to patients and their caregivers. Through the KaryForward Program, Karyopharm Therapeutics Inc. provides the following benefits:
- Insurance Coverage
- Financial Assistance
- Support and Resources
KIMMTRAK CONNECT offers proactive services and support tailored to your eligible patients' individual needs. Each patient is paired with a dedicated nurse case manager who provides one-on-one guidance throughout the treatment journey.
Click here to watch a short video and learn more about what KIMMTRAK CONNECT has to offer or call the help line at 844-775-2273 for immediate assistance.
Please click here for KIMMTRAK® (tebentafusp-tebn) Prescribing Information, including BOXED WARNING for Cytokine Release Syndrome (CRS).
LIBTAYO Surround Patient Support Program can help patients access LIBTAYO® (cemiplimab-rwlc) and navigate the health insurance process. It provides:
- Access and reimbursement support, including benefits investigation, prior authorization, and claims assistance
- Financial support, including the Patient Assistance Program and Commercial Copay Program, where eligible copay claims can be submitted online at LIBTAYOCopayCard.com
- Additional support through dedicated Patient Navigators, including appointment reminders, local support groups, transportation services, and educational resources
For more information, call LIBTAYO Surround at 1.877.LIBTAYO (1.877.542.8296) Option 1, Monday–Friday 8:00 AM–8:00 PM Eastern time.
Lilly is dedicated to developing medicines that make life better. We support patients as well as those who look after and care for them. We’re determined to do our part to help patients and their loved ones.
That’s why we created the Lilly Oncology Support Center - A single platform where you and your patients can access support resources for all Lilly Oncology Products. For a complete list of Lilly Oncology Products, please visit LillyOncology.com.
Through the Lilly Oncology Support Center, we strive to offer individualized treatment support for eligible patients prescribed a Lilly Oncology product.
For those who qualify, we can help with:
- Review of financial-assistance options:
- Savings card programs
- Independent patient-assistance foundations
- Reimbursement (eligibility determination, benefits investigation, prior authorization assistance, and appeals information)
Services For Patients Living With a Chronic or Severe Illness
Meijer has been in business for more than 85 years, including 55 years serving pharmacy patients. We’re a private, family-owned business that treats our patients and team members like family.
Our financial reimbursement specialists may help identify ways to reduce costs for specialty medications.
Please contact Meijer Specialty Pharmacy at 1-855-263-4537 for additional information.
ACT is a 2-part program designed to assist insured patients with reimbursement issues and to provide product support for qualified individuals lacking coverage.
Patient Support: 866-363-6379
The Mirati & Me Patient Support Program offers comprehensive support services for eligible patients, caregivers, and healthcare professionals, including personalized education and financial resources to help patients who have been prescribed Mirati medications start and stay on treatment.
To learn more about the Mirati & Me program, visit www.miratiandme.com or call 1-844-647-2842 8 AM to 8 PM ET, Monday-Friday.
The myBeiGene program can provide your office with reimbursement and payment support, education, and connections to third-party advocacy organizations to help your patients gain access to BRUKINSA. Dedicated Oncology Nurse Advocates also provide personalized support for your patients and their caregivers based on each patient's individual needs.
The first personalized ctDNA test to identify molecular residual disease and optimize treatment decisions.
At Natera, we understand that some of our patients are unable to pay for our services due to financial hardship or other circumstances. That's why, through our Compassionate Care Program, patients who qualify will pay no more than $149 per test, and may owe nothing, depending on their financial situation.
The Novartis Patient Assistance Foundation is committed to providing access to our medicines for those most in need. If you are experiencing financial hardship and have limited or no prescription coverage for your medicines, you may be eligible to receive your Novartis medicines at no cost.
Pfizer is committed to supporting patients throughout their treatment journey. With Pfizer Oncology Together, patients prescribed a Pfizer Oncology medication get personalized support, including help identifying financial assistance options and connections to resources that may help with some of their day-to-day challenges.
Pfizer Oncology Together can:
- Assist patients with benefits verification, prior authorizations, appeals, and specialty pharmacy coordination
- Help connect patients with financial assistance resources—regardless of their insurance coverage
- Direct healthcare providers and office staff to Pfizer Field Reimbursement Managers who can help address specific access issues—in person or over the phone
- Connect and assist healthcare providers with online portals that provide registered users with access and financial assistance resources
- Provide patients with one-on-one support from Care Champions, who have social work experience, and can connect them to resources that may help with some of their daily needs. This includes educational information as well as connections to emotional support resources and independent organizations that help eligible patients with transportation and lodging for treatment-related appointments*
Please visit PfizerOncologyTogether.com for more details or contact your local Field Reimbursement Manager or AP&R Director to learn more.
*Some services are provided through third-party organizations that operate independently and are not controlled by Pfizer. Availability of services and eligibility requirements are determined solely by these organizations.
Pfizer Oncology Together™ is a trademark of Pfizer Inc.
Pfizer RxPathways offers a range of support services, including insurance counseling, co-pay help, and medicines provided free or at a savings. Eligibility requirements are the same as for the previous programs and vary by type of assistance. Patients who are currently receiving their medicines through Pfizer Helpful Answers and FirstResource will be automatically enrolled in Pfizer RxPathways and do not have to take any action to continue receiving their medicines.
PharmaEssentia SOURCE offers personalized support services designed to help you successfully start and stay on BESREMi (ropeginterferon alfa-2b-njft).
Our dedicated PharmaEssentia SOURCE Case Managers are here to help you:
- Answer any questions you may have
- Understand your insurance coverage
- Find resources for financial support
Call us at 800-700-5053 between 8:00 AM and 8:00 PM ET, Monday through Friday.
SERVICES TO HELP MAKE NERLYNX ACCESSIBLE
For more information on the Puma Patient Lynx™ Support Program:
1-855-816-5421, Monday–Friday, 9 AM–8 PM ET
RIGEL ONECARE will help patients get started with TAVALISSE
By assisting with reimbursement approval, including benefit investigations, prior authorizations, and appeals
By determining eligibility and facilitating enrollment in copay and financial assistance programs
By contacting patients and answering their questions so they start TAVALISSE with the information they need
CareASSIST is committed to helping remove barriers for eligible patients and caregivers throughout their treatment journey. We consider it our mission to deliver reliable access and financial assistance to eligible patients prescribed Sanofi oncology medications. Our Care Managers are available to answer questions, provide more information, and support patients and providers every step of the way.
Questions? We’re here to help. To learn more about the CareASSIST program and additional support options, please contact a dedicated Care Manager at 1-833-WE+CARE (1-833-930-2273), Mon – Fri, 9 AM – 8 PM ET, or visit our website at SanofiCareASSIST.com.
SeaGen Secure is a comprehensive reimbursement support hotline and patient assistance program for ADCETRISTM (brentuximab vedotin). Reimbursement counselors are available to provide coverage, coding and reimbursement information in addition to case management for our patient assistance programs. Patient assistance is available to uninsured and underinsured patients that have been prescribed ADCETRIS. Eligibility for patient assistance is based on gross family household income, residency and diagnosis. Additional program services include Benefit Investigations, assistance with underpaid/denied claims, ADCETRIS policy information and alternate funding research.
Please contact SeaGen Secure at 855-473-2436 or www.SeaGenSecure.com to obtain an enrollment form or for additional information.
ServierONE is your all-in-one resource for help with the cost of treatment, determining insurance coverage, one-on-one support, and access to additional resources and educational tools. Financial Assistance for Tibsovo (ivosidenib tablets), Oncospar (pegaspargase) and Asparlas (calaspargase pegol-mknl).
Stemline ARC® is a program that offers access and reimbursement support, financial assistance programs, and resources for healthcare professionals (HCPs) and patients throughout their treatment with ORSERDU.
Helping you help your patients obtain access to TAIHO ONCOLOGY PRODUCTS
Accessing treatments can be challenging at times. Taiho Oncology Patient Support™ offers personalized services to give patients, caregivers and healthcare professionals (HCPs) the help they need in getting started with Taiho Oncology Products. This includes insurance verification, help with medication costs, and treatment plan support.
Takeda Oncology Here2Assist™ is a comprehensive support program committed to helping patients navigate coverage requirements, identify available financial assistance, and connect with helpful resources throughout their treatment.
VELCADE® is a part of the Takeda Oncology Here2Assist family, but eligible patients and providers can receive financial support through the VELCADE Reimbursement Assistance Program (VRAP). The VRAP enrollment form is available at www.VELCADE-hcp.com.
Visit www.Here2Assist.com or call 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET.
For information on co-pay assistance, visit the Takeda Oncology Co-Pay Assistance Program at www.takedaoncologycopay.com/.
TerSera is committed to help remove the financial and access barriers that so often get in the way of patients who are prescribed ZOLADEX® (goserelin acetate implant) and VARUBI® (rolapitant) tablets.
At GSK, we understand that a cancer diagnosis can be overwhelming for patients and loved ones. Treatment considerations and costs can add undue stress, especially if you’re unsure what coverage options are available or how to access them. Together with GSK Oncology is here to help, offering patients and healthcare professionals a variety of access and reimbursement services for all GSK oncology products—all in one place.
We offer personalized services right from the start of your prescribed Blueprint Medicines therapy.
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!